Litigation Details for SENJU PHARMACEUTICAL CO., LTD. v. LUPIN, LTD. (D.N.J. 2014)

SENJU PHARMACEUTICAL CO., LTD. v. LUPIN, LTD. (D.N.J. 2014)

Docket		Date Filed	2014-01-31
Court	District Court, D. New Jersey	Date Terminated	2016-08-29
Cause	15:1126 Patent Infringement	Assigned To	Jerome B. Simandle
Jury Demand	None	Referred To	Karen M. Williams
Parties	SENJU PHARMACEUTICAL CO., LTD.
Patents	8,129,431; 8,669,290; 8,754,131; 8,871,813; 8,927,606
Attorneys	MAYRA VELEZ TARANTINO
Link to Docket	External link to docket

Details for SENJU PHARMACEUTICAL CO., LTD. v. LUPIN, LTD. (D.N.J. 2014)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2014-01-30	1		United States Patent No. 8,129,431 (“the ’431 patent”), arising under the United States patent laws, Title… COUNT FOR PATENT INFRINGEMENT 11. The U.S. Patent and Trademark Office …Office (“PTO”) issued the ’431 patent on March 6, 2012. The ’431 patent claims, inter alia, formulations of…Senju is the assignee of the ’431 patent. A copy of the ’431 patent is attached hereto as Exhibit A. …. COMPLAINT FOR PATENT INFRINGEMENT Plaintiffs Senju Pharmaceutical	External link to document
2015-11-17	107		the various patents covering Plaintiffs’ Prolensa® product: U.S. Patent Nos. 8,129,431 (“the ’431…of U.S. Patent No. 8,129,431, IPR2015-00903 (Innopharma); Inter Partes Review of U.S. Patent No. 8,754,131… The patents at issue in this case, namely, the ’431 patent, the ’290 patent, the ’131 patent, the …431 patent”), 8,669,290 (“the ’290 patent”), 8,754,131 (“the ’131 patent”), 8,871,813 (“the ’813 patent…patent”), and 8,927,606 (“the ’606 patent”) (collectively, the “patents- in-suit”). Before the	External link to document